Comparison of different screening tests for detecting diabetic foot neuropathy

Acta Neurologica Scandinavica

Volumn 112, Issue 6, 2005, Pages 409-413

  Forouzandeh, F ^a   Ahari, A Aziz ^a   Abolhasani, F ^a   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Michigan Neuropathy Disability Score; Monofilament; Neuropathy; Sign score; Symptom score

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC NEUROPATHY; EARLY DIAGNOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICHIGAN NEUROPATHY DISABILITY SCORE; NEUROFILAMENT; OUTPATIENT; RELIABILITY; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SENSORY NEUROPATHY; SYMPTOM;

ADULT; AGED; DIABETIC FOOT; DIABETIC NEUROPATHIES; DISABILITY EVALUATION; EARLY DIAGNOSIS; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; SENSITIVITY AND SPECIFICITY; STATISTICS;

EID: 28144445266     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00494.x     Document Type: Article

References (35)

1. FRYKBERG RG, ARMSTRONG DG, GIURINI J et al. Diabetic foot disorders: A Clinical practice guideline. For the American College of Foot and Ankle Surgeons and the American College of Foot and Ankle Orthopedics and Medicine. Diabetic Foot Disorders. J Foot Ankle Surg 2000;39(Suppl. 5):1-60.
2. SANGYEOUP L, HYEUNHO K, SANGHAN C, YOUGSOON P, YUNJIN K, BYEUNGMAN C. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy. J Korean Med Sci 2003;18:103-7.
3. AMERICAN DIABETES ASSOCIATION. Consensus development conference on diabetic foot wound care. Diabetes Care 1999;22:1354-60.
4. LARIJANI B, FOROUZANDEH F. Diabetic foot disorders, a review article. Iran J Diabetes Lipid Disord 2003;2:93-103.
5. INLOW S, ORSTED H, SIBBAD RG. Best practices for the prevention, diagnosis and treatment of diabetic foot ulcers. Ostomy Wound Manage 2000;46:55-68.
6. PALUMBO PJ, MELTON LI. Peripheral vascular disease and diabetes. In: Diabetes in America. National Diabetes Data Group (US) 2nd edn. Washington, DC: NIH Publication, 1985;XV:1-21.
7. REIBER GE, BOYKO EI, SMITH DG. Lower extremity foot ulcers and amputations in diabetes. In: Harris MI, Cowie C, Stem MP, eds. Diabetes in America, 2nd edn. Washington, DC: NIH Publication, 1995:409-28.
8. FRYKBERG RG, HABERSHAW GM, CHRZAN IS. Epidemiology of the diabetic foot: ulcerations and amputations. In: Veves A, ed. Contemporary endocrinology: clinical management of diabetic neuropathy. Totowa, NJ: Humana Press, 1998;273-90.
9. SOROUSH A, FOROUZANDEH F, HAMEDI E, AZIZAHARI A, SHAHI B. Principles of clinical approach to wounds and burns, 1st edn. Iran: Tehran University of Medical Sciences, 2003.
10. GIBBONS GW, ELIOPOULOS GM. Infection of the diabetic foot. In: Kozak GP, Campbell DR, Frykberg RG, Habershaw GM, eds. Management of diabetic foot problems. Philadelphia, PA: WB Saunders, 1995;121-9.
11. LEVIN ME. Foot lesions in patients with diabetes mellitus. Endocrinol Metab Clin North Am 1996;25:447-62.
12. GERLOF DV, DIDI MWK, WILLEM JJA. Patient education for preventing diabetic foot ulceration, a systemic review. Endocrinol Metab Clin North Am 2002;31:633-58.
13. BELCH JJ, TOPOL EJ, AGNELLI G, BERTRAND M. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003;163:884.
14. HIATT WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608.
15. REIBER GE, VILEIKYTE L, BOYKO EJ et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-62.
16. FRYKBERG RG, LAVERY L, PHAM H, HARVEY C, HARKLESS L, VEVES A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998;21:1714-9.
17. MCNEELY MJ, BOYKO E, AHRONI JH. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 1995;18:216-9.
18. BOYKO EJ, AHRONI JH, STENSEL V, FORSBERG RC, DAVIGNON DR, SMITH DO. A prospective study of risk factors for diabetic foot ulcer: The Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036-42.
19. BOULTON AJM. The pathway to ulceration. In: Boulton AJM, Connor H, Cavanagh PR, eds. The foot in diabetes, 3rd edn. Chichester, NY: J Wiley & Sons, 2000;19-31.
20. MCCULLOCH DK. Evaluation of the diabetic foot. In: Rose BD, ed. UpToDate. Wellesley, MA: CD ROM, Vol. 12, No.1; 2004 http://www.uptodate.com
21. MCPHAIL IR, SPITTELL PC, WESTON SA, BAILEY KR. Intermittent claudication: an objective office-based assessment. J Am Coll Cardiol 2001;37:1381.
22. SPITTELL JA. Diagnosis and management of occlusive peripheral arterial disease. Curr Probl Cardiol 1990;15:1.
23. BOYA F, LARIJANI B, PAJOUHI M, LOTfi J, NORAII MM, BANDARIAN F. Peripheral neuropathy in diabetic patients and its contribution factors. Iran J Diabetes Lipid Disord 2004;3:41-6.
24. LUNETTA M, LE MOLI R, GRASSO G, SANGIORGIO L. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract 1998;39:165-72.
25. KULLER LH, SHEMANSKI L, PSATY BM. Sub clinical disease as an independent risk factor for cardiovascular disease. Circulation 1995;92:720.
26. KEMPCZINSKI RF. Segmental volume plethysmography in the diagnosis of lower extremity arterial occlusive disease. J Cardiovasc Surg 1982;23:125.
27. KOHLER TR, NANCE DR, CRAMER MM. Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: a prospective study. Circulation 1987;76:1074.
28. VINIK A, PARK TS, STANSBERRY KB, PITTENGER GL. Diabetic neuropathies. Diabetologia 2000;43:957-73.
29. PERKINS BA, OLALEYE D, ZINMAN B, BRIL V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001;24:250-6.
30. RAHMAN M, GRIN SJ, RATHMANN W, WAREHAM NJ. How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med 2003;20:368-74.
31. MCNEELY MJ, BOYKO EJ, AHRONI JH. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: How great are the risks? Diabetes Care 1995;18:216.
32. MEIJER JWG, SMIT AJ, SONDEREN EV, GROOTHO JW, EISMA WH, LINKS TP. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med 2002;19:962-5.
33. MEIJER JWG, SONDEREN EV, BLAAUWWIEKEL EE et al. Diabetic Neuropathy Examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 2000;23:750-3.
34. YOUNG MJ, BOULTON AJ, MACLEOD AF. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150.
35. FRANKLIN GM, KAHN LB, BAXTER J, MARSHALL JA, HAMMAN RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus: The San Luis Valley Diabetes Study. Am J Epidemiol 1990;131:633-43.